Evidence map›Paper›PMID 21641486›Full record

ReviewSeminars in perinatology2011

Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates.

Sanjiv B Amin, Angelo A Lamola

Registry-linked trialAbstract readReview
In one paragraph

Review in Seminars in perinatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02691156 (Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02691156 completednot on this mapstarted 2016, after this paper: background citation

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

TypeobservationalSponsorStanford UniversityRan2016 to 2018Enrolled143ConditionsBilirubin-induced Neurologic Dysfunction, Hyperbilirubinemia, Kernicterus, Infant, PrematureArmsBilirubin Binding Capacity, End-tidal Carbon Monoxide, Carboxyhemoglobin
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Fluid supplementation for neonatal unconjugated hyperbilirubinaemia.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Effects of lipid emulsions on unbound bilirubin and response to phototherapy in preterm infants.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sanjiv B AminDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. Sanjiv_amin@urmc.rochester.edu
Angelo A Lamola
Stanford University · USUniversity of Rochester Medical Center · US

Funding

Bilirubin-induced Auditory Neuropathy in PretermsK23DC006229 · NIDCD · UNIVERSITY OF ROCHESTER · PI AMIN, SANJIV B · 2004 to 2008
$966k
Enamel Hypoplasia and Early Childhood Caries in Preterms with JaundiceR21DE021161 · NIDCR · UNIVERSITY OF ROCHESTER · PI AMIN, SANJIV B · 2010 to 2011
$343k
Predicting Bilirubin-induced Auditory Toxicity in Infants with Severe JaundiceR03HD061084 · NICHD · UNIVERSITY OF ROCHESTER · PI AMIN, SANJIV B · 2009 to 2010
$153k
NICHD NIH HHS R03 HD061084NIDCD NIH HHS K-23 DC 006229NIDCD NIH HHS K23 DC006229NIDCR NIH HHS R21 DE021161PHS HHS 1R21DEO21161
6 · The paper itself

Abstract

Neonatal jaundice (hyperbilirubinemia), which is extremely common in neonates, can be associated with neurotoxicity. A safe level of bilirubin has not been defined in either premature or term infants. Emerging evidence suggest that the level of unbound (or "free") bilirubin has a better sensitivity and specificity than total serum bilirubin for bilirubin-induced neurotoxicity. Although recent studies suggest the usefulness of free bilirubin measurements in managing high-risk neonates, including premature infants, no widely available method exists to assay the serum free bilirubin concentration. To keep pace with the growing demand, in addition to reevaluation of old methods, several promising new methods are being developed for sensitive, accurate, and rapid measurement of free bilirubin and bilirubin binding capacity. These innovative methods need to be validated before adopting for clinical use. We provide an overview of some promising methods for free bilirubin and binding capacity measurements with the goal to enhance research in this area of active interest and apparent need.

Indexed as

BilirubinFluorometryHumansInfant, NewbornJaundice, NeonatalSerum AlbuminSerum Albumin, HumanSpectrophotometryalbumin-bilirubin complexBilirubinSerum AlbuminSerum Albumin, Human

Identifiers

PMID21641486
PMCPMC3111023
OpenAlexW1978542133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.